CLNN biotech catalysts & pipeline

CLENE INC · Data as of 2026-09-08

Upcoming catalysts

Q4 2026

Clene expects to submit a New Drug Application for CNM-Au8 ® in ALS under the accelerated approval pathway in early fourth quarter of 2026